Young Teresa L. (CIK 1814656) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-18). Recent activity: Buy MCRB (231 shares), Sell MCRB (75 shares), Buy MCRB (3,998 shares), Buy MCRB (132 shares), Buy MCRB (98 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-18 | Seres Therapeutics, Inc. (MCRB) | See Remarks | Buy | 231 | $0 |
| 2026-02-18 | Seres Therapeutics, Inc. (MCRB) | See Remarks | Sell | 75 | $635 |
| 2025-11-18 | Seres Therapeutics, Inc. (MCRB) | See Remarks | Buy | 3,998 | $0 |
| 2025-11-18 | Seres Therapeutics, Inc. (MCRB) | See Remarks | Buy | 132 | $0 |
| 2025-11-18 | Seres Therapeutics, Inc. (MCRB) | See Remarks | Buy | 98 | $0 |
| 2025-11-18 | Seres Therapeutics, Inc. (MCRB) | See Remarks | Sell | 1,042 | $18,027 |
| 2025-08-19 | Seres Therapeutics, Inc. (MCRB) | See Remarks | Buy | 133 | $0 |
| 2025-08-19 | Seres Therapeutics, Inc. (MCRB) | See Remarks | Buy | 97 | $0 |
| 2025-08-19 | Seres Therapeutics, Inc. (MCRB) | See Remarks | Sell | 59 | $982 |
| 2025-05-19 | Seres Therapeutics, Inc. (MCRB) | See Remarks | Buy | 133 | $0 |
| 2025-05-19 | Seres Therapeutics, Inc. (MCRB) | See Remarks | Buy | 98 | $0 |
| 2025-05-19 | Seres Therapeutics, Inc. (MCRB) | See Remarks | Sell | 63 | $459 |
Source: SEC Form 4 filings · as of 2026-02-18